The 20 Best Nasopharyngeal Carcinoma Doctors Near Me in Maryland, US

Maie John is an Otolaryngologist practicing medicine in Baltimore, Maryland. Dr. John is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy. Dr. John is board certified in Head And Neck Surgery.

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic. Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center. Make A Gift. Dr. Quon is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Dry Mouth, Gastrostomy, and Prostatectomy. Dr. Quon is board certified in American Board Of Radiology.

Dr. Tanguy Seiwert is an oncologist in Baltimore, caring for patients with head and neck cancer. He serves as the director of the Head and Neck Cancer Oncology Disease Program and the co-director of the Bloomberg~Kimmel Institute for Immunotherapy at the Head and Neck Cancer Program at the Johns Hopkins School of Medicine. Dr. Seiwert earned his M.D. at Johannes Gutenberg Universität in Mainz, Germany. He completed his residency at the Duke University School of Medicine and performed a fellowship in hematology/oncology at the University of Chicago Medicine Mitchell Hospital-Hyde Park. Dr. Seiwert joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Seiwert was director of the Head and Neck Cancer Program at the University of Chicago. Dr. Seiwert’s research interests include immunologic and genomic profiling. He has given numerous invited talks on head and neck cancer both nationally and internationally. Dr. Seiwert served as chief editor for Frontiers in Head and Neck Cancer and as an editorial board member for the Journal of Clinical Oncology and Oral Oncology. He is a reviewer for multiple medical journals, including Lancet Oncology, Annals of Oncology and Clinical Cancer Research. He has been recognized by the American Association for Clinical Oncology for multiple Merit Awards and a Young Investigator Award. He was a member of the NCI Head and Neck Cancer Steering Committee, and is a member of the American Association for Clinical Oncology, the Society for Immunotherapy of Cancer, and the European Society of Clinical Oncology. Dr. Seiwert is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Glioma, Laryngeal Cancer, Tongue Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy. Dr. Seiwert is board certified in American Board Of Internal Medicine.

Dr. Ana Kiess's clinical focus is on the treatment of prostate cancer and head and neck cancers with external beam radiotherapy and radiopharmaceutical therapies. Her research concentrates on the integration of new radiopharmaceutical therapies and dosimetry techniques into the clinic. Dr. Kiess received her bachelors of science degree in chemical engineering from the University of Virginia, after which she obtained a doctorate of medicine and a doctorate of philosophy degree in biomedical engineering from Duke University. Following medical school, she matriculated to the resident staff at Memorial Sloan Kettering Cancer Center, receiving extensive oncologic training and research experience. She also completed a postdoctoral research fellowship at Johns Hopkins University in the Department of Radiology. Make A Gift. Dr. Kiess is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Laryngeal Cancer, Acinic Cell Carcinoma of Salivary Glands, Gastrostomy, and Adenoidectomy. Dr. Kiess is board certified in American Board Of Radiology.

Gerald Sokol, MD, specializes in medical oncology and radiation oncology and is board-certified by the American Board of Internal Medicine and the American Board of Radiology. He practices at UPMC Western Maryland Medical and Radiation Oncology. Dr. Sokol received his medical degree from Indiana University School of Medicine - IU Health University Hospital. Dr. Sokol is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Prostate Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Sokol is board certified in American Board Of Internal Medicine , American Board Of Radiology , and American Board Of Internal Medicine.

Jason Molitoris is a Radiologist and a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Molitoris is rated as an Advanced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Adult Soft Tissue Sarcoma, Familial Prostate Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Molitoris is board certified in American Board Of Radiology.

Robert Monteleone is a primary care provider, practicing in Family Medicine in Elkton, Maryland. Dr. Monteleone is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. His clinical expertise encompasses Type 2 Diabetes (T2D), Constrictive Pericarditis, Nasopharyngeal Carcinoma, and Maturity Onset Diabetes of the Young. Dr. Monteleone is board certified in American Board Of Family Medicine.

Wayne Koch is a national and international leader in head and neck oncologic surgery, caring for patients with cancers of the oral cavity, salivary gland, larynx, hypopharynx, oropharynx and thyroid. Among Dr. Koch's landmark publications are studies demonstrating how key molecular events such as p53 mutation and human papillomavirus (HPV) contribute to the development of head and neck cancer. His peer-reviewed publications include six articles in the New England Journal of Medicine. Dr. Koch is also involved in humanitarian outreach focused on training surgeons in several African nations. He has served as president of the American Head and Neck Society, the national organization of head and neck cancer surgeons in the USA. Dr. Koch is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Human Papillomavirus Infection, Laryngectomy, and Gastrostomy. Dr. Koch is board certified in Head And Neck Surgery.

Dr. Carole Fakhry is a head and neck surgical oncologist at Johns Hopkins and treats the breadth of patients with head and neck cancers, including cancers of the tonsils, base of tongue, mouth, larynx, thyroid, salivary gland (parotid, submandibular gland) and skin cancers among others. She is the Chief of the Division of Head and Neck Surgery and Director of the Head and Neck Cancer Center. She also serves as director of the head and neck group in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the head and neck surgical oncology fellowship. She is the associate editor for Oral Oncology and serves on several editorial boards. After an undergraduate degree at Stanford University, she completed medical school, residency in otolaryngology head and neck surgery, and a fellowship in head and neck surgical oncology at Johns Hopkins. She has also received a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She is presently a professor in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery, Oncology, and Johns Hopkins Bloomberg School of Public Health Department of Epidemiology. Her research interest focuses on the role of human papillomavirus (HPV) in head and neck squamous cell cancer. She has demonstrated that the presence of HPV confers a prognostic advantage to individuals with oropharyngeal cancer and that HPV is associated with unique clinical characteristics. In addition to the clinical implications of HPV in head and neck cancer, she is co-principal investigator of a large study to understand screening individuals at “high risk” of malignancy and evaluating imaging modalities to improve diagnostics and early detection of HPV- related head and neck cancer. Dr. Fakhry is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Human Papillomavirus Infection, Head and Neck Squamous Cell Carcinoma (HNSCC), Salivary Gland Tumors, Laryngectomy, and Gastrostomy. Dr. Fakhry is board certified in Head And Neck Surgery.

Richard F. Ambinder, M.D., Ph.D., currently serves as the James B. Murphy Professor of Oncology and the Director of the Division of Hematologic Malignancies at the Johns Hopkins Kimmel Cancer Center. He is program co-leader of the Hematologic Malignancies and Bone Marrow Transplantation Program and leads the AIDS Malignancy Consortium (AMC) site at Johns Hopkins and the AMC Translational Sciences Working Group nationally. Dr. Ambinder graduated from Harvard College with a Bachelor’s degree in biochemistry, after which he received his medical degree from the Johns Hopkins University School of Medicine before completing his residency at the Johns Hopkins Hospital. He also earned his Ph.D. in pharmacology from the Johns Hopkins University, and completed his oncology fellowship at Johns Hopkins. Within the clinic, Dr. Ambinder is active in the treatment of lymphoma and Kaposi’s sarcoma. Dr. Ambinder’s research is focused on exploring opportunities to prevent or treat cancer with viral infections. Virus-associated tumors are among the most common malignancies in certain populations and regions. For instance, Burkitt's lymphoma (EBV) and Kaposi's sarcoma (KSHV) are common in equatorial Africa, nasopharyngeal carcinoma (EBV) is common in southern Chinese populations or those with southern Chinese origins, and immunoblastic lymphomas (EBV) are common in immunocompromised patients (organ transplant recipients, AIDS patients, etc). Thus, Dr. Ambinder’s new approaches to prevention, diagnosis, and treatment stand to have a direct impact on the lives of cancer patients around the globe. Additionally, the study of how viruses can impact these tumors is important in creating model systems for the development of new approaches to cancer care. Currently, many immunotherapies target unidentified antigens, making the measurement of relevant immune responses problematic at best. However, in EBV-associated tumors the antigens are well defined, thus allowing the Ambinder lab to define the epitope-specific cellular immune responses. As a result of this breakthrough, interventions designed to alter immune response —whether they be vaccine based interventions, adoptive immunotherapy interventions, or pharmacologic interventions — may all be assessed in terms of relevant surrogate markers. Much in the same way the treatment of Hodgkin's lymphoma with radiotherapy and chemotherapy paved the way for the modern approach to cancer treatment more broadly, the treatment of EBV-associated tumors (including Hodgkin's lymphoma) may pave the way to the more generalized use of these modalities to treat a myriad of cancer types. Dr. Ambinder is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration. Dr. Ambinder is board certified in American Board Of Internal Medicine.

Christine Gourin, M.D. M.P.H., is a head and neck surgical oncologist and palliative medicine specialist who treats patients with head and neck tumors, including tumors of the skin, melanoma, oral cavity, larynx, oropharynx, neck, salivary glands, sinuses, and skull base. Dr. Gourin received her medical degree from the State University of New York-Health Science Center at Brooklyn/Downstate Medical Center. Dr. Gourin trained in General Surgery and Otolaryngology-Head and Neck Surgery at the University of Vermont, followed by a fellowship in Advanced Head and Neck Oncologic Surgery at the University of Pittsburgh and a fellowship in Hospice and Palliative Medicine at Johns Hopkins University. She has authored over 200 peer-reviewed journal articles, 24 book chapters and two books: Medical and Surgical Management of Thyroid and Parathyroid Diseases and The Johns Hopkins Patient Guide to Head and Neck Cancer. She is on the Editorial Board of The Laryngoscope and is a reviewer for numerous other head and neck surgery journals. Dr. Gourin is a nationally and internationally recognized expert in quality of care and outcomes with a lifelong interest in improved symptom management, communication, access to high-quality affordable care, and palliative medicine in head and neck cancer. She has an active head and neck surgical oncology practice and has been named to America’s Top Physicians and Best Doctors in America annually since 2005. She is the Director of the Johns Hopkins Head and Neck Cancer Supportive Care Clinic. Dr. Gourin is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Tongue Cancer, Laryngectomy, and Gastrostomy. Dr. Gourin is board certified in American Board Of Internal Medicine and Head And Neck Surgery.

Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia. Dr. Mener is board certified in American Board Of Internal Medicine.

William Regine is a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Regine is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, and Anal Cancer. Dr. Regine is board certified in American Board Of Radiology.

Wojtek Mydlarz, director of Johns Hopkins Head and Neck Surgery in the National Capital Region, specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, skull base, thyroid, skin and soft tissue. Dr. Mydlarz is a medical officer and a clinical and research collaborator in the head and neck surgery branch of the National Institutes of Health (NIH). His research interests include evaluating both surgical and nonsurgical treatment outcomes in patients with head and neck cancer. He is interested in the complex molecular biology of head and neck cancer, as well as potential clinical applications of novel targeted cancer therapies. He is actively involved in clinical trial development and implementation at the NIH and Johns Hopkins. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Mydlarz completed his internship and residency in otolaryngology–head and neck surgery at The Johns Hopkins Hospital. Additionally, he completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health and specialized fellowship training in head and neck surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Mydlarz has contributed to numerous professional publications, authored a variety of articles and book chapters, and has been invited to give many lectures. He serves on the editorial board for Oral Oncology and Laryngoscope Investigative Otolaryngology, and is a journal reviewer for Oral Oncology, Head and Neck, Laryngoscope and JAMA Otolaryngology–Head and Neck Surgery. Dr. Mydlarz is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Tissue Biopsy. Dr. Mydlarz is board certified in Head And Neck Surgery.

Nyall London has a unique clinical practice focused on the care of patients with sinonasal and skull base cancers. As one of the few surgeons trained in both head and neck cancer surgery, as well as rhinology and skull base surgery, he offers patients comprehensive sinonasal tumor surgical care, including open and endoscopic approaches as well as neck dissection surgery. Dr. London has developed notable patient education events about the multidisciplinary and long-term care of patients with sinonasal malignancies. Additionally, he is an innovator of clinical trials for these rare tumors, with open clinical trial options available and multiple others in development. Internationally recognized for his expertise in the care of patients with sinonasal and skull base cancers, Dr. London was an associate editor for the first international consensus statement on sinonasal tumors, and was appointed president of the International Network for Sinonasal Cancer Research (2024–26). He directs a research laboratory at the National Cancer Institute/National Institutes of Health focused on therapeutic advances and mechanisms of sinonasal tumorigenesis. Dr. London has published more than 130 peer-reviewed research articles, reviews and book chapters, including co-first author publications in Nature, Nature Medicine, Science Translational Medicine and Nature Cell Biology. He earned his medical and doctoral degrees from the University of Utah, and completed his residency in otolaryngology–head and neck surgery at Johns Hopkins. He also accomplished a fellowship in open and endoscopic head and neck and skull base surgery at The Ohio State University, under the direction of Dr. Ricardo Carrau. Dr. London is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Craniectomy. Dr. London is board certified in Head And Neck Surgery.

Dr. Won Jin Ho is a physician-scientist at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins who focuses on cancer immunology and tumor microenvironment research. Dr. Ho received his BS and MS in Biomedical Engineering from University of California, Los Angeles, and his MD from Wayne State University School of Medicine. Dr. Ho completed a research track internal medicine residency as an NIH F32 postdoctoral fellow at Case Western Reserve University and subsequently completed a medical oncology fellowship at Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as the recipient of ASCO Young Investigator Award and AACR Immuno-Oncology Fellowship. Dr. Ho's overarching research interest is to develop novel immunotherapeutic strategies even against immune-resistant cancers by first understanding the immune responses to current therapeutics. Dr. Ho focuses on determining the systemic and in situ changes by leveraging cutting-edge technologies. With his expertise in mass cytometry, Dr. Ho is co-leading many of the systemic and spatial immune profiling efforts at Johns Hopkins. Dr. Ho also is developing novel small-molecule cancer therapeutics and methodologies for translational discovery. Dr. Ho is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Fibrolamellar Carcinoma, Liver Cancer, and Hepato-Pancreato-Biliary Surgery. Dr. Ho is board certified in American Board Of Internal Medicine.

Brandi Page, M.D., is an assistant professor of radiation oncology and molecular sciences for Johns Hopkins Radiation Oncology Department at Suburban Hospital and a radiation oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Page has expertise in treating all types of cancer and, for the last several years, has become a highly sought-after specialist in the National Capitol Region (NCR-MD/DC/VA) for her expertise in treating head and neck and brain/central nervous system tumors. In Dr. Page's role with Johns Hopkins she has brought new complex radiotherapy services to the facility and facilitated the team building environment for collaborating practitioners and caregivers in the region. Dr. Page also serves on the Cancer Committee for Sibley and Suburban Hospitals for the American Cancer Society, which brings together multidisciplinary care providers to collaborate on initiatives for continued excellence. She is a teaching faculty member at the Johns Hopkins School of Medicine for medical students, residents and fellows, is the current director of radiation oncology fellowships, initiating and growing the first radiation oncology fellowship at the institution a year after the initiation of the proton center. Dr. Page earned her medical degree at Albany Medical College, completed residency in radiation oncology at the Huntsman Cancer Institute at the University of Utah, and fellowship in translational radiation oncology at Wake Forest University Medical Center, where she earned the Service Excellence in Patient Care Award. At Johns Hopkins she has won awards for clinical excellence nominated by peers many years in a row and a Faculty of the Year award for her teaching efforts. Dr. Page is a member of the American Society of Therapeutic Radiation Oncology, a diplomate of the American Board of Radiology, and a Fellow of the American College of Radiation Oncology. Dr. Page has served on the Board of Directors for Radiating Hope and currently serves on the Board of Directors for Courage Unmasked/911-4-HNC (a Head and Neck Cancer support organization). Dr. Page frequently serves as a sought after reviewer for peer reviewed articles and has served as the Continuing Medical Education Editor for the International Journal of Radiation Oncology Biology Physics (IJROBP). Dr. Page believes the best way to empower patients is with knowledge and partnership and she looks forward to partnering with patients in treating their condition, and helping them successfully get through their treatment and maximize opportunities for a happy healthy life after treatment. Make A Gift LinkedIn https://www.linkedin.com/in/brandi-page-968650b0. Dr. Page is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Brain Tumor, Throat Cancer, Laryngeal Cancer, Glioma, and Gamma Knife Radiosurgery. Dr. Page is board certified in American Board Of Radiology.

Godswill Okoji is a primary care provider, practicing in Family Medicine in Hyattsville, Maryland. Dr. Okoji is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Hypertension, Glucocorticoid-Remediable Aldosteronism, Familial Hypertension, End-Stage Renal Disease (ESRD), and Gastrostomy.

Nicholas Farrell is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Farrell is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Iron Deficiency Anemia. Dr. Farrell is board certified in American Board Of Internal Medicine.

Elizabeth Nichols is a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Nichols is rated as an Experienced provider by MediFind in the treatment of Nasopharyngeal Carcinoma. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Angiosarcoma, Cervical Cancer, and Neuroendocrine Carcinoma of the Cervix. Dr. Nichols is board certified in American Board Of Radiology.